This scenario was confirmed by a parallel work showing that CK2 was overexpressed and hyperactive in CLL and its inhibition correlated with increased PTEN activity and inactivation of PKC, a PI3K target. Here, PTEN is linked to B-cell chronic lymphocytic leukemia.